Media OutReach
Diabetes Association Unveils T-CaReMe Taipei Declaration at the Asia Diabetes International Conference
In an effort to achieve a target of 80% of patients controlling the three highs and protecting kidney health within eight years, Taiwan leads the international trend of precise prevention with public-private collaboration in response to the new health goals of Healthy Taiwan.
TAIPEI, TAIWAN – Media OutReach Newswire – 28 March 2025 – As the global aging process accelerates, the prevention and care of chronic diseases have become a top priority for countries worldwide. The Taiwanese government has actively responded to international trends by promoting the “Healthy Taiwan” policy and launching the “Three Highs Prevention 888 Plan.” At the third “Healthy Taiwan Promotion Committee” meeting held last month, new goals were announced to reduce the standardized mortality rate of chronic diseases related to the three highs by one-third by 2030, aiming to strengthen chronic disease prevention and control measures through public-private collaboration. In alignment with the vision of “Healthy Taiwan” and the 888 Plan, and connecting with the international trend of “precision prevention” of chronic disease management, the Taiwan Diabetes Association formally presented the “T-CaReMe Precision Care Taipei Declaration” at the Asia Diabetes International Conference.
With a comprehensive national health insurance system in place, Taiwan ensures that every high-risk group can receive proactive prevention and personalized management early on, demonstrating international competitiveness in the accessibility and completeness of chronic disease care. To address the increasingly severe challenge of chronic diseases—particularly hypertension, hyperlipidemia, diabetes (the three highs), and chronic kidney disease—the Taiwan Diabetes Association unveiled the “T-CaReMe Precision Care Taipei Declaration” at the 17th Scientific Meeting of the Asian Association for the Study of Diabetes (AASD). This declaration was made in witness of various governmental agencies, academic institutions, and medical associations, including the Asian Association for the Study of Diabetes, the National Health Insurance Administration, the Health Promotion Administration, Academia Sinica, the National Health Research Institutes, the Taiwan Society of Nephrology, and the Taiwan Society of Cardiology. The declaration responds to the government’s vision of “Healthy Taiwan” and the goals of the 888 Plan, which focus on delaying disability and increasing life expectancy. It proposes a comprehensive health care model for chronic diseases centered around risk stratification, precision medicine, and digital management, further promoting the integration of holistic health care and medical services, while fostering interdisciplinary collaboration to drive a new paradigm of chronic disease prevention and treatment.
New Health Goals for Healthy Taiwan: Reduce Standardized Mortality Rate of Chronic Diseases Related to the Three Highs by One-Third
The Taiwan Diabetes Association Unveils T-CaReMe Declaration to Promote Precision Care Blueprint for Kidney Health in Relation to the Three Highs
With the trends of aging, prolonged illness, and the emergence of chronic diseases at younger ages, chronic disease prevention and management have become a global focus. Taiwan is following international trends by establishing the “Healthy Taiwan Promotion Committee,” which has set two major health goals for the next eight years: to increase the average life expectancy of the population from 79 to 82 years and to reduce the proportion of unhealthy life expectancy from 10% to 8%. To strengthen chronic disease management, the government recently announced a target at the Healthy Taiwan Promotion Committee meeting to “reduce the standardized mortality rate of chronic diseases related to the three highs by one-third by 2030,” along with comprehensive strategies promoting healthy lifestyles, obesity prevention, and holistic management of chronic diseases, through public-private collaboration to enhance health policies and reduce the risks of chronic diseases and disabilities.
The Taiwan Diabetes Association has released the “T-CaReMe Precision Care Taipei Declaration,” making “Kidney Protection in Relation to the Three Highs” a core focus. Through the T-CaReMe initiative, the vision of “risk stratification, precision medicine, digital management, and increased life expectancy” is implemented, along with five key action frameworks: promoting precise risk diagnostics, standardized clinical guidelines, personalized health management, data sharing, and interdisciplinary collaboration. The goal is to ensure that 80% of patients with the three highs and kidney disease achieve control of blood glucose, blood pressure, and blood lipids while ensuring that 80% of kidney disease patients receive care and medication guidance from care managers, thereby enhancing survival rates and improving health quality, creating a stronger defense for chronic disease care in the population.
Risk Stratification × Precision Medicine: T-CaReMe Initiative Launches a New Future for Chronic Disease Management
International Experts Gather to Establish Taiwan as a Demonstration Base for Chronic Disease Care
The T-CaReMe Taipei Declaration focuses on precise risk diagnostic classification and assessment, aiming to accurately identify high-risk populations and improve the effectiveness of chronic disease management. Through expert consensus and clinical risk stratification, as well as medical guidelines, the initiative integrates clinical data with international standards to ensure that patients receive personalized health management and appropriate treatment. Additionally, the declaration emphasizes collaboration across nations and disciplines, engaging in precision medicine and research achievements in the realm of chronic diseases in the Asia-Pacific region, influencing public health policies and improving chronic disease care outcomes, while developing a more precise and accessible holistic health care approach, solidifying Taiwan’s position as a regional demonstration base.
The meeting brought together experts and scholars from the National Health Insurance Administration, the Health Promotion Administration, Academia Sinica, and the National Health Research Institutes, along with representatives from the International Diabetes Federation (IDF-WPR) and the Asian Association for the Study of Diabetes (AASD), to witness the official launch of the “T-CaReMe Precision Care Taipei Declaration.” The Taiwan Diabetes Association stated that the declaration not only lays the groundwork for Taiwan’s development blueprint in precision chronic disease care and kidney health management related to the three highs but also aims to promote upgrades in chronic disease management models, enhance interdisciplinary collaboration, and build a more comprehensive health care system, driving improvements in global chronic disease care quality and prosperity starting from Taiwan.
Dr. Wu Mai-Su, President of the Taiwan Society of Nephrology, noted that although Taiwan has developed risk stratification and data-driven personalized treatment, standardized guidelines have yet to be incorporated, and clinical applications still have room for improvement, especially in the integrated management of kidney disease and diabetes. He expressed that through the T-CaReMe initiative, interdisciplinary collaboration can facilitate the integration of chronic kidney disease risk and comorbid management with diabetes and hypertension, contributing to higher patient survival rates and better kidney function maintenance. Dr. Li Yi-Heng, President of the Taiwan Society of Cardiology, emphasized that risk stratification and data-driven personalized management can effectively reduce the incidence of cardiovascular events, further strengthening the health defenses of the population. Dr. Hsu Hui-Heng, Deputy Director of the National Health Research Institutes, stated that the application of precision medicine will play a crucial role in future chronic disease management. The National Health Research Institutes is actively exploring several initiatives, such as using AI technology and big data to establish smart risk prediction systems, believing that under the visionary actions of the T-CaReMe initiative, there will be further optimization of precise predictions for cardiovascular, kidney, and metabolic disease risks, providing better scientific bases for the prevention of primary and secondary complications and organ damage associated with chronic diseases, thus realizing Taiwan’s health blueprint.
Aligning with International Standards! T-CaReMe Initiative Promotes a New Paradigm of Precision Chronic Disease Management
Taiwan will construct a comorbidity risk database within two years. The T-CaReMe initiative calls on all sectors to build a defense against chronic diseases.
In recent years, the Health Promotion Administration has actively promoted the “Scientific Disease Calculation Center” and risk prediction tools to enhance public health literacy and self-management awareness, delaying the onset of chronic diseases through proactive health education. Meanwhile, the National Health Insurance Administration has introduced AI risk stratification tools and a tiered care system, promoting the “Everyone’s Health Platform” and comprehensive, patient-centered care to improve care efficiency and resource utilization. Professor Chen Chih-Hong, Vice Convener of the Healthy Taiwan Promotion Committee, stated that the T-CaReMe initiative aligns closely with government policies integrating prevention and treatment, reflecting the core spirit advocated by the 888 Plan. In the future, it is hoped that all sectors will work together to deepen interdisciplinary collaboration and public-private integration, creating a sustainable and resilient model for chronic disease care.
The global healthcare community has identified precise risk assessment and personalized treatment as key trends in chronic disease management. The latest diabetes care guidelines particularly address the comorbidity risks associated with the three highs and kidney disease, suggesting earlier intervention in cardiovascular and kidney health management and enhancing data-driven diagnostic models. The importance of early screening and treatment is emphasized, and precise risk assessment and integration of patient data will be core development directions for future chronic disease management. These international trends indicate that global chronic disease management is moving towards precision medicine, digital monitoring, and interdisciplinary integration, which aligns closely with the goals of the T-CaReMe initiative.
The Taiwan Diabetes Association took action as early as 2023, collaborating with 12 medical institutions in Taiwan to join the iCaReMe global registry program. Through interdisciplinary integrated care, patient tracking, and the application of clinical data, it not only provides more precise risk assessments and patient profiles but also effectively monitors and optimizes treatment outcomes, which has been shown to improve patients’ health conditions. Chairman Huang Jian-Ning shared that the short-term goal of the T-CaReMe initiative is to construct a representative database within two years. By analyzing lifestyle factors, it aims to more accurately assess the comorbidity risks of different patients. Implementing a comprehensive model for precision chronic disease care requires not only efforts from the medical community but also active participation from government agencies, academic institutions, industry partners, and civic groups to jointly promote data integration and personalized health management, ensuring that risk stratification and standardized guidelines are continually refined, while enhancing chronic disease management effectiveness in Taiwan and the Asia-Pacific region.
Yutaka Seino, Chair of the Asian Association for the Study of Diabetes conference, stated that Taiwan has consistently been at the forefront of chronic disease prevention and treatment in Asia, and he hopes that through public-private collaboration and interdisciplinary cooperation, Taiwan can lead the global improvement of chronic disease care quality.
Hashtag: #DiabetesAssociation
The issuer is solely responsible for the content of this announcement.
Media OutReach
TELOSIN Introduces “The Dual Transformation,” Pairing Y PRO Red and Y PRO Blue with the New Lumiactive Collection
The new skincare system brings together FDA-cleared, NASA-inspired light technology, complementary formulations and award-winning patented design by Karim Rashid, following a Hong Kong launch attended by more than 2,000 guests
HONG KONG SAR – Media OutReach Newswire – 21 July 2026 – TELOSIN has introduced “The Dual Transformation,” a new approach to personalised at-home skincare built around two dedicated light-based beauty devices—the Y PRO Red and Y PRO Blue—and the complementary Lumiactive Collection.
The launch brings together advanced light-based technology, targeted skincare formulations and award-winning patented design created in collaboration with internationally acclaimed designer Karim Rashid.
Rather than incorporating multiple generalised modes within a single device, TELOSIN developed two distinct devices and two dedicated skincare pathways.
Y PRO Red is designed for a rejuvenation-focused skincare routine, supporting the appearance of firmness, texture and radiance.
Y PRO Blue is designed for routines focused on blemish-prone, oily or visibly unsettled skin.
The devices combine FDA-cleared technology with light-based innovation inspired by scientific developments associated with NASA research.
Introducing the Lumiactive Collection
The Y PRO devices are accompanied by the new Lumiactive Collection, comprising:
- LUMIRED Red LED Treatment Gel
- LUMIBLUE Blue LED Treatment Gel
- Blue Light Defense Cream
Together, the devices and complementary formulations establish TELOSIN’s connected Prepare, Treat, Protect approach to skincare.
The dedicated Lumiactive treatment gels are designed to prepare the skin for the corresponding Y PRO routine, while Blue Light Defense Cream completes the ritual as part of the brand’s wider daily skincare approach.
By developing the devices and formulations as one connected collection, TELOSIN aims to make advanced light-based skincare easier to understand, personalise and incorporate into regular at-home routines.
The result is a complete ecosystem built around two targeted transformations: a red-light pathway focused on rejuvenation and a blue-light pathway focused on skin clarity and balance.
Scientific Insight Behind TELOSIN
TELOSIN has expanded the scientific conversation surrounding the launch through its expert video series, “The Science Behind Telosin,” available on the brand’s website.
The series features expert perspectives from two medical professionals:
Dr. Omer Wolf, MD, a specialist in plastic and reconstructive surgery and advanced facial aesthetic procedures.
Dr. Uri Berger, MD, a specialist in aesthetic medicine with extensive international medical training and experience.
Through the expert series, TELOSIN provides consumers with accessible information about the principles behind light-based skincare and the evolving relationship between professional aesthetic knowledge, beauty technology and at-home routines.
The inclusion of medical perspectives within the wider educational programme reflects TELOSIN’s commitment to supporting product innovation through informed scientific discussion and responsible consumer education.
Award-Winning Patented Design by Karim Rashid
The Y PRO Red and Y PRO Blue were created in collaboration with Karim Rashid, one of the world’s most recognised contemporary designers.
The devices feature award-winning patented design that combines Rashid’s distinctive visual language with TELOSIN’s advanced beauty technology.
Their fluid silhouettes, individual colour identities and ergonomic forms were developed not simply to contain sophisticated technology, but to transform the devices into desirable contemporary objects that can become a natural part of the user’s daily beauty environment.
The collaboration reflects TELOSIN’s belief that advanced skincare devices should deliver a sophisticated combination of performance, simplicity, comfort and emotional connection.
“The Dual Transformation” Unveiled to More Than 2,000 Guests in Hong Kong
The complete collection was officially presented on 30 June 2026 through “The Dual Transformation,” an immersive launch experience held at WTC Mall in Hong Kong.
The large-scale event welcomed more than 2,000 guests, including consumers, members of the Hong Kong media, influencers, beauty industry professionals and invited partners.
The launch featured internationally acclaimed designer Karim Rashid, MIRROR member Ian Chan, celebrated actress and singer Linda Chung, and Dr. Harvey Ho.
Karim Rashid introduced the creative thinking behind the award-winning patented design of the devices, while Dr. Harvey Ho discussed the different applications and skincare pathways associated with red and blue light technology.
Ian Chan and Linda Chung joined the launch presentation to experience the two routines and demonstrate how the Y PRO devices and complementary Lumiactive formulations can be incorporated into contemporary at-home skincare.
“The Dual Transformation demonstrates that advanced beauty technology does not need to feel clinical or complicated,” said Dr. Harvey Ho.
“By bringing together two dedicated light-based devices with complementary Lumiactive formulations, TELOSIN has created a more focused and intuitive approach to at-home skincare. The distinction between the red and blue light pathways also helps consumers better understand how different technologies can support different skincare needs.”
With more than 2,000 guests attending, the event marked a major public introduction of TELOSIN’s broader product ecosystem: two targeted devices, three complementary skincare formulations and one connected approach to personalised light-based skincare.
A Complete Dual Skincare System
With Y PRO Red, Y PRO Blue and the Lumiactive Collection, TELOSIN is introducing more than two individual beauty devices.
“The Dual Transformation” represents a complete skincare system built around clearly defined objectives, dedicated formulations and award-winning patented design.
It reflects the brand’s wider ambition to make sophisticated light-based technology more personalised, intuitive and accessible, while maintaining the premium design experience expected by contemporary beauty consumers.
Hashtag: #TELOSIN
https://www.telosin.com
https://www.instagram.com/telosin_official/?hl=en
The issuer is solely responsible for the content of this announcement.
About TELOSIN
TELOSIN develops premium at-home skincare devices and complementary formulations that bring together advanced light-based technology, scientific insight, award-winning patented design and an intuitive user experience.
Through continued product development and collaborations with internationally recognised designers and medical professionals, TELOSIN aims to make sophisticated beauty technology more personalised, accessible and desirable.
TELOSIN products are available online atwww.telosin.com, at The Mineral Boutique stores, through selected premium retailers and at leading clinics.
For further information, expert videos and product details, visitwww.telosin.com.
Media OutReach
SearchInform: A Risky Game – How FIFA World Cup 2026 Led to Mass Corporate Data Leaks
Experts claim that corporate employees in Southeast Asia are neglecting cybersecurity rules due to their love for football, leading to an increase in fraud cases.
SINGAPORE – Media OutReach Newswire – 21 July 2026 – Although the tournament itself took place in North America, Asia’s massive football fan base created the perfect conditions for data leaks.
Fraudsters are capitalizing on football fans by creating fake streaming platforms and malicious Android applications that steal saved passwords and account credentials directly from browsers. Criminals are also setting up fraudulent websites, as well as sending phishing emails to company employees disguised as gifts, promotions, and office betting pools.
“During major global events, the corporate security perimeter is under huge stress,” said Francis Yeoh, Country Director at SearchInform Malaysia. “Employees access streaming websites from corporate devices to watch matches live. Traditional network-edge security is insufficient—the real danger comes from the employee side of the fence. Employees could watch a translation on a malware-infested website, they could download streaming applications with hidden malware, or use corporate credentials to register for fraudulent giveaways.”
According to Group-IB and the FBI, from August 2025 to June 2026, more than 4,300 fake websites were registered fully mimicking FIFA interfaces, ticketing systems, streaming platforms, and World Cup employment portals.
How Organizations Can Reduce Cyber Risks During Football Season
- Monitor the use of corporate devices. Remind employees that corporate workstations should not be used for personal purposes, including streaming, downloading unofficial apps, or visiting suspicious websites. This measure alone can help reduce exposure to many malware threats.
- Strengthen password security. Monitor risky password practices, as some employees may reuse corporate credentials for personal services. If one of these services is compromised, corporate accounts and systems may be put at risk as well.
- Enforce multi-factor authentication. Apply MFA for privileged employees on a regular basis and temporarily strengthen authentication requirements for remote employees during high-risk periods. This provides an additional layer of protection against unauthorized access.
- Monitor data access patterns. Track who accesses critical information, from where, and monitor its transmission to prevent data loss. Make sure protection also covers cloud services, as corporate data is no longer limited to on-premises storage.
Hashtag: #SearchInform #Cybersecurity, #FIFA2026, #DataProtection
The issuer is solely responsible for the content of this announcement.
About SearchInform
SearchInform is an information security and risk management product vendor as well as an MSS provider. The company’s clients are more than 4000 companies in 20+ countries. Today, the team has products and services for comprehensive protection against insider threats at all levels of corporate information systems: FileAuditor (the DCAP class solution); DLP system with extended functionality; Risk Monitor (advanced AI-powered platform for internal threat mitigation); SIEM system, Information Security outsourcing service.
More than 500 international buyers from 55 economies have confirmed participation
KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 21 July 2026 – The Malaysia External Trade Development Corporation (MATRADE) invites Malaysian companies to seize new global business opportunities by registering for its flagship International Sourcing Programme (INSP) at the upcoming 22nd Malaysia International Halal Showcase (MIHAS) at MITEC, Kuala Lumpur from 23 to 26 September 2026.
Building on the strong momentum of INSP MIHAS 2025, which generated RM3.63 billion in sales, this year’s edition is seeing strong international buyer interest, reinforcing MIHAS’ position as a leading global halal trade platform. INSP MIHAS 2026 features key products and services categories including:
- Agricultural Produce;
- Apparel, Garments and Accessories;
- Beverages;
- Education;
- Fashion Accessories and Textiles;
- Footwear;
- Franchise;
- Gifts, Souvenirs and Jewellery;
- Gloves;
- Islamic Financial Services;
- Information and Communication Technology;
- Logistics;
- Machinery and Equipment;
- Packaging and Containers;
- Palm Oil Products;
- Pet Products;
- Pharmaceuticals;
- Toiletries and Cosmetics; and
- Prepared Food.
Beyond the conventional halal food and beverage segment, this year’s edition is also seeing growing interest in services sectors.
INSP MIHAS connects pre-qualified international buyers with Malaysian halal product and service exporters through pre-arranged one-on-one business meetings across key halal sectors. As buyer meeting slots are limited and allocated through a structured matching process, Malaysian companies are strongly encouraged to register early via the online portal.
According to MATRADE’s Chief Executive Officer (CEO), Mr. Abu Bakar Yusof, “Since the inception of MIHAS in 2004, the International Sourcing Programme (INSP) has generated over RM20.62 billion in export sales for Malaysian companies, with the participation of nearly 8,000 international buyers, benefiting 10,600 Malaysian sellers through 67,200 structured business meetings.
For this year, we are targeting the participation of approximately 300 buyers, of which 50 are premium buyers, reflecting our commitment to attracting high-quality decision-makers and creating greater business opportunities for Malaysian companies. We are also targeting RM2 billion in export sales under the INSP component for MIHAS 2026. To date, we have received interest from more than 500 international buyers across 55 economies, and we encourage Malaysian companies to register early to maximise their business matching opportunities.”
MIHAS 2026 is expected to generate total sales of RM4.50 billion, including export sales from the INSP. “As it stands, 15% of the interested buyers comprise returning buyers, demonstrating sustained confidence in Malaysian exporters and the compelling value proposition they continue to offer in global markets,” he added. This year’s INSP has attracted buyers from 55 different economies.
Malaysian exporters can register through the INSP MIHAS online portal and MADANI Digital Trade Platform (MDTP) before 31st July 2026 and take advantage of one of MIHAS’ most impactful business matching initiatives.
Hashtag: #MIHAS2026
The issuer is solely responsible for the content of this announcement.
Malaysia External Trade Development Corporation (MATRADE)
For more information, please contact:
Aninawati Saleh
Head of Corporate Communication
Malaysia External Trade Development Corporation (MATRADE)
Tel (Direct) : 03 – 6207 7077 (7826)
Email : co***********@*********ov.my
About Malaysia International Halal Showcase (MIHAS) 2026
Since it began in 2004, the Malaysia International Halal Showcase (MIHAS) has grown into a major platform for Halal trade and has helped strengthen the global industry’s position in Halal standards, governance, and market access. Recognised as a Guinness World Records holder and hosted by the Ministry of Investment, Trade and Industry (MITI) with the Malaysia External Trade Development Corporation (MATRADE) as organiser, MIHAS now covers 14 sectors, from food and beverages and pharmaceuticals to Islamic finance, modest fashion, personal care, technology, services, and Muslim-friendly tourism. The 22nd edition of MIHAS, themed “Shaping Trust, Driving Resilience”, will focus on regulated-by-design governance and technology-enabled trade.
About MATRADE
The Malaysia External Trade Development Corporation (MATRADE) was established on 1 March 1993 as the national trade promotional arm under Malaysia’s Ministry of Investment, Trade and Industry (MITI).
MATRADE’s primary role is to assist Malaysian exporters in developing and expanding their export markets. Aligned with Malaysia’s commercial diplomacy efforts, MATRADE is the nation’s trade facilitator and champion of Malaysian-made products and services on the global stage.
